Skip Navigation LinksHome > Current Issue > Contributor Index

May 15, 2015 - Volume 29 - Issue 8 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 8 Next
Author Name Article
Abecasis, Ana B.

Lack of evidence for the selection of E138 mutations by first-generation non-nucleoside reverse transcriptase inhibitors in patients infected with HIV-1 non-B subtypes

Purchase Access
PDF
+ Favorites
Request Permissions
Albanese, Anthony

Role of intestinal myofibroblasts in HIV-associated intestinal collagen deposition and immune reconstitution following combination antiretroviral therapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Alwan, Ferras

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Amin, Janaki

Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions

Limited reporting of major harms in studies of initial combination antiretroviral therapy: a systematic review

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ances, Beau M.

A better screening tool for HIV-associated neurocognitive disorders: is it what clinicians need?

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Ardeshna, Kirit M.

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Asmuth, David M.

Role of intestinal myofibroblasts in HIV-associated intestinal collagen deposition and immune reconstitution following combination antiretroviral therapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Barnes, Eleanor

Apparent spontaneous clearance of chronic hepatitis C virus infection in a HIV co-infected patient with decompensated cirrhosis: a case report

Open Access
PDF
+ Favorites
Request Permissions
Barrett, Jeffrey S.

Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults

Open Access
Supplemental Author Material
Abstract
PDF
+ Favorites
Request Permissions
Bil, Janneke P.

What do Dutch MSM think of preexposure prophylaxis to prevent HIV-infection? A cross-sectional study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bower, Mark

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Brouillette, Marie-J.

A better screening tool for HIV-associated neurocognitive disorders: is it what clinicians need?

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Brown, Anthony

Apparent spontaneous clearance of chronic hepatitis C virus infection in a HIV co-infected patient with decompensated cirrhosis: a case report

Open Access
PDF
+ Favorites
Request Permissions
Burns, Fiona

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Byrne, Ruth

Acute porphyria precipitated by efavirenz

Purchase Access
PDF
+ Favorites
Request Permissions
Canetta, Pietro A.

Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Carr, Andrew

Limited reporting of major harms in studies of initial combination antiretroviral therapy: a systematic review

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Carrieri, Maria Patrizia

Securing opioid substitution treatment access and quality for people who inject drugs

Purchase Access
PDF
+ Favorites
Request Permissions
Catalano, Renae

Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults

Open Access
Supplemental Author Material
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 8 Next